The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.










Independent, unbiased, up-to-date

Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options

Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug

Potential interactions and side effects summarized in comparison charts

With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek

Clearly written patient information sheets available for download as printable PDF files




This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.



New in this edition:






Neuroscience-based nomenclature - added to product availability tables

Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also updates to SSRI use in pregnancy and antidepressant augmentation strategies

Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment

Mood stabilisers chapter sections on Lithium and Anticonvulsants have been extensively revised

New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta (lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules)